Dementia Risk Reduced by GLP-1 Agonists
In summary, patients with type 2 diabetes who use GLP-1 agonists, such as Ozempic, have a lower incidence of dementia.
Read MoreIn summary, patients with type 2 diabetes who use GLP-1 agonists, such as Ozempic, have a lower incidence of dementia.
Read MoreResearchers looked at relationships between metabolic syndrome (MetS) and neuroimaging and cognitive outcomes in dementia-free adults in a new study
Read MoreResearchers conducted a comprehensive analysis and quantitative evaluation of the epidemiological evidence regarding the relationship between screen time exposure and
Read MoreLower air temperatures have long been associated with pediatric asthma flare-ups in children with the condition, as many parents are
Read MoreAn association between gut microbes and Parkinson’s disease (PD) has been shown in a recent study. Researchers discovered that PD
Read MoreReactivating suppressed metabolic pathways in cancer cells is a novel way to treat cancer, according to research conducted by an
Read MoreThe high incidence and mortality rates of gastrointestinal (GI) malignancies, which include gastric, small bowel, colorectal, and esophageal carcinomas, pose
Read MoreA worldwide cohort of researchers released a new study today in JAMA Network Open that offers the most recent information
Read MoreResearchers at the University of Bristol have shown that community-based testing and treatment in response to the HIV epidemic among
Read MoreResearchers examined the reactogenicity and effects of the coronavirus disease 2019 (COVID-19) vaccine on pregnancy outcomes related to severe acute
Read More